Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA606292
Max Phase: Preclinical
Molecular Formula: C11H20N5O14P3
Molecular Weight: 539.22
Molecule Type: Small molecule
Associated Items:
ID: ALA606292
Max Phase: Preclinical
Molecular Formula: C11H20N5O14P3
Molecular Weight: 539.22
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN1CN(C2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@H](O)[C@@H]2O)c2nc(N)nc(O)c21
Standard InChI: InChI=1S/C11H20N5O14P3/c1-15-3-16(8-5(15)9(19)14-11(12)13-8)10-7(18)6(17)4(28-10)2-27-32(23,24)30-33(25,26)29-31(20,21)22/h4,6-7,10,17-18H,2-3H2,1H3,(H,23,24)(H,25,26)(H2,20,21,22)(H3,12,13,14,19)/t4-,6-,7-,10?/m0/s1
Standard InChI Key: BUJQMJUTTBGELS-VKZRYZQFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 539.22 | Molecular Weight (Monoisotopic): 539.0220 | AlogP: -2.23 | #Rotatable Bonds: 8 |
Polar Surface Area: 288.02 | Molecular Species: ACID | HBA: 15 | HBD: 8 |
#RO5 Violations: 3 | HBA (Lipinski): 19 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 0.89 | CX Basic pKa: 3.87 | CX LogP: -3.80 | CX LogD: -9.22 |
Aromatic Rings: 1 | Heavy Atoms: 33 | QED Weighted: 0.16 | Np Likeness Score: 1.09 |
1. Noonan T, Brown N, Dudycz L, Wright G.. (1991) Interaction of GTP derivatives with cellular and oncogenic ras-p21 proteins., 34 (4): [PMID:2016705] [10.1021/jm00108a010] |
Source(1):